Long-term treatment with romiplostim in patients with chronic immune thrombocytopenia: safety and efficacy (Q33406032)

26 July 2017

title

Long-term treatment with romiplostim in patients with chronic immune thrombocytopenia: safety and efficacy (English)

1 reference

chronic immune thrombocytopenia

26 July 2017

1 reference

1 reference

1 reference

James B Bussel

1 reference

26 July 2017

Adrian Newland

1 reference

26 July 2017

David J Kuter

1 reference

26 July 2017

Ross I Baker

1 reference

26 July 2017

Roger M Lyons

1 reference

26 July 2017

Jeffrey Wasser

1 reference

26 July 2017

Jean-Francois Viallard

1 reference

26 July 2017

Gail Macik

1 reference

26 July 2017

Mathias Rummel

1 reference

26 July 2017

Kun Nie

1 reference

26 July 2017

Susie Jun

1 reference

26 July 2017

language of work or name

English

0 references

publication date

22 February 2013

1 reference

British Journal of Haematology

26 July 2017

published in

1 reference

26 July 2017

volume

161

1 reference

26 July 2017

1 reference

26 July 2017

page(s)

411-423

1 reference

Mechanisms of thrombocytopenia in chronic autoimmune thrombocytopenic purpura. Evidence of both impaired platelet production and increased platelet clearance

26 July 2017

cites work

1 reference

AMG 531, a thrombopoiesis-stimulating protein, for chronic ITP.

21 January 2018

1 reference

Eltrombopag for the treatment of chronic idiopathic thrombocytopenic purpura

21 January 2018

1 reference

Safety and efficacy of long-term treatment with romiplostim in thrombocytopenic patients with chronic ITP.

21 January 2018

1 reference

Effect of eltrombopag on platelet counts and bleeding during treatment of chronic idiopathic thrombocytopenic purpura: a randomised, double-blind, placebo-controlled trial

21 January 2018

1 reference

Immune thrombocytopenic purpura (ITP) plasma and purified ITP monoclonal autoantibodies inhibit megakaryocytopoiesis in vitro

21 January 2018

1 reference

Eltrombopag for management of chronic immune thrombocytopenia (RAISE): a 6-month, randomised, phase 3 study

21 January 2018

1 reference

How I treat idiopathic thrombocytopenic purpura (ITP).

21 January 2018

1 reference

Evaluation of bleeding and thrombotic events during long-term use of romiplostim in patients with chronic immune thrombocytopenia (ITP).

21 January 2018

1 reference

Autoimmune (idiopathic) thrombocytopenic purpura.

21 January 2018

1 reference

Autoimmune Platelet Destruction: Idiopathic Thrombocytopenic Purpura

21 January 2018

1 reference

Romiplostim safety and efficacy for immune thrombocytopenia in clinical practice: 2-year results of 72 adults in a romiplostim compassionate-use program

21 January 2018

1 reference

Thrombopoietin and thrombopoietin mimetics in the treatment of thrombocytopenia

21 January 2018

1 reference

Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura: a double-blind randomised controlled trial

21 January 2018

1 reference

Evaluation of bone marrow reticulin formation in chronic immune thrombocytopenia patients treated with romiplostim

21 January 2018

1 reference

Romiplostim or Standard of Care in Patients with Immune Thrombocytopenia

21 January 2018

1 reference

21 January 2018

1 reference

Thrombocytopenia caused by the development of antibodies to thrombopoietin

21 January 2018

1 reference

Suppression of in vitro megakaryocyte production by antiplatelet autoantibodies from adult patients with chronic ITP

21 January 2018

1 reference

The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia

21 January 2018

1 reference

An open-label, unit dose-finding study of AMG 531, a novel thrombopoiesis-stimulating peptibody, in patients with immune thrombocytopenic purpura

21 January 2018

1 reference

The immune thrombocytopenic purpura (ITP) bleeding score: assessment of bleeding in patients with ITP.

21 January 2018

1 reference

International consensus report on the investigation and management of primary immune thrombocytopenia

21 January 2018

1 reference

Case records of the Massachusetts General Hospital. Case 11-2010. A 69-year-old woman with lethargy, confusion, and abnormalities on brain imaging

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/BJH.12260

1 reference

26 July 2017

1 reference